Skip to main content

Uremia alters HDL composition and cholesterol efflux capacity

Background

Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease, but the effect of advanced renal disease on the composition and function of HDL is not well understood.

Methods

Mass spectrometry and biochemical analyses were used to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis.

Results

We identified a significant increase in the amount of acute-phase protein serum amyloid A1, albumin, lipoprotein-associated phospholipase A2, and apoC-III composing uremic HDL. Furthermore, uremic HDL contained reduced phospholipids and increased triglycerides and lysophospholipids. With regard to function, these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages.

Conclusions

In summary, the altered composition of HDL in renal disease seems to inhibit the cardioprotective properties of HDL. Assessing HDL composition and function in renal disease may help to identify patients at increased risk for cardiovascular disease.

Acknowledgements

This work was supported by the Austrian Science Fund FWF (grants P21004-B02 and P22976-B18).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Gunther Marsche.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Holzer, M., Birner-Grünberger, R., Stojaković, T. et al. Uremia alters HDL composition and cholesterol efflux capacity. BMC Pharmacol Toxicol 13, A15 (2012). https://doi.org/10.1186/2050-6511-13-S1-A15

Download citation

Keywords

  • Renal Disease
  • Functional Impairment
  • Lipid Composition
  • Cardiovascular Mortality
  • Uremia